[go: up one dir, main page]

MX2009009318A - Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea. - Google Patents

Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea.

Info

Publication number
MX2009009318A
MX2009009318A MX2009009318A MX2009009318A MX2009009318A MX 2009009318 A MX2009009318 A MX 2009009318A MX 2009009318 A MX2009009318 A MX 2009009318A MX 2009009318 A MX2009009318 A MX 2009009318A MX 2009009318 A MX2009009318 A MX 2009009318A
Authority
MX
Mexico
Prior art keywords
diarrhoea
probiotics
caesarean section
infants born
reduce episodes
Prior art date
Application number
MX2009009318A
Other languages
English (en)
Inventor
Norbert Sprenger
Marie-Claire Fichot
Karl-Josef Huber-Haag
Florence Rochat
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2009009318A publication Critical patent/MX2009009318A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

El uso de bacterias probióticas en la fabricación de un medicamento o composición nutritiva terapéutica para prevenir o tratar la diarrea en bebés nacidos por operación cesárea.
MX2009009318A 2007-03-28 2008-03-27 Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea. MX2009009318A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07105074A EP1974743A1 (en) 2007-03-28 2007-03-28 Probiotics to Improve Gut Microbiota
PCT/EP2008/053638 WO2008116904A1 (en) 2007-03-28 2008-03-27 Probiotics to reduce episodes of diarrhoea in infants born by caesarean section

Publications (1)

Publication Number Publication Date
MX2009009318A true MX2009009318A (es) 2009-09-10

Family

ID=38051788

Family Applications (4)

Application Number Title Priority Date Filing Date
MX2009010252A MX337667B (es) 2007-03-28 2008-03-27 Combinacion simbiotica para mejorar la microbiota intestinal.
MX2009009931A MX2009009931A (es) 2007-03-28 2008-03-27 Probioticos para reducir el desarrollo de alergia en lactantes nacidos por cesarea.
MX2009009318A MX2009009318A (es) 2007-03-28 2008-03-27 Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea.
MX2009009442A MX2009009442A (es) 2007-03-28 2008-03-27 Probioticos para mejorar la microbiota intestinal.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
MX2009010252A MX337667B (es) 2007-03-28 2008-03-27 Combinacion simbiotica para mejorar la microbiota intestinal.
MX2009009931A MX2009009931A (es) 2007-03-28 2008-03-27 Probioticos para reducir el desarrollo de alergia en lactantes nacidos por cesarea.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2009009442A MX2009009442A (es) 2007-03-28 2008-03-27 Probioticos para mejorar la microbiota intestinal.

Country Status (15)

Country Link
US (4) US20100086527A1 (es)
EP (6) EP1974743A1 (es)
CN (4) CN101652079A (es)
AU (4) AU2008231702B2 (es)
BR (4) BRPI0809356A2 (es)
CA (4) CA2679081A1 (es)
ES (2) ES2434566T3 (es)
MX (4) MX337667B (es)
MY (1) MY151137A (es)
PL (2) PL2131680T3 (es)
PT (2) PT2131859T (es)
RU (4) RU2009139667A (es)
UA (2) UA97662C2 (es)
WO (4) WO2008116904A1 (es)
ZA (3) ZA200907731B (es)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
EP1993576B1 (en) * 2006-03-07 2015-10-21 Nestec S.A. Synbiotic mixture
EP2035023A1 (en) * 2006-06-13 2009-03-18 Nestec S.A. Prevention and treatment of otitis media with non-pathogenic bacterial strains
EP2147678A1 (en) * 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
JP2012510800A (ja) * 2008-12-05 2012-05-17 ネステク ソシエテ アノニム 低出生体重児において使用するための組成物
EP2206506A1 (en) * 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
CN102481323A (zh) * 2009-07-31 2012-05-30 雀巢产品技术援助有限公司 含有益生菌和所选营养物的用于母乳喂养的婴幼儿或宠物的营养组合物
EP2289527B1 (en) * 2009-08-25 2018-02-21 Nestec S.A. Bifidobacterium longum and functional GI disorders
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
EP2452575A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Array of age-tailored nutritional formula with probiotics
EP2465507A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
EP2455387A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
WO2012089782A1 (en) * 2010-12-29 2012-07-05 Nestec S.A. Fiber and probiotics for reducing intestinal symptoms related to stress
EE05750B1 (et) 2011-02-25 2015-06-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
RU2748839C2 (ru) 2011-06-20 2021-05-31 Х.Дж. Хайнц Компани Брэндс Ллк Композиции, способы и наборы для стимулирования мукозальной иммунной системы
WO2013032744A2 (en) 2011-08-17 2013-03-07 Nume Health, Llc Composition and use of a formulation to increase the ratio of gastrointestinal microbiota in phylum bacteriodites to microbiota of firmuctes phylum
MX354727B (es) * 2011-10-18 2018-03-16 Nestec Sa Composicion para uso en la promocion de absorcion de magnesio y/o retencion de magnesio.
US10238694B2 (en) 2011-12-01 2019-03-26 The University Of Tokyo Human-derived bacteria that induce proliferation or accumulation of regulatory T cells
JP6115094B2 (ja) * 2012-11-15 2017-04-19 株式会社Ｇｓユアサ 蓄電素子及び蓄電素子の製造方法
MX370692B (es) 2013-05-10 2019-12-19 Heinz Co Brands H J Llc Probióticos y métodos de uso.
MX379145B (es) * 2013-11-15 2025-03-11 Soc Des Produits Nestle S A Star Ficomposiciones para prevenir o tratar alergias en infantes a partir de o alimentados por madres no secretoras mediante el suministro de oligosacaridos fucosilados, particularmente entre los niños en riesgo o nacidos por cesárea.
CN105722409A (zh) * 2013-11-15 2016-06-29 雀巢产品技术援助有限公司 用于预防或治疗婴儿和幼儿的坏死性小肠结肠炎的组合物
ES2895380T3 (es) * 2013-11-15 2022-02-21 Nestle Sa Composiciones para su uso en la prevención o tratamiento de la enterocolitis necrotizante en bebés y niños pequeños
CN105722514A (zh) 2013-11-15 2016-06-29 雀巢产品技术援助有限公司 用于预防或治疗剖腹产婴儿或幼儿的坏死性小肠结肠炎的组合物
EP3182841B1 (en) 2014-08-18 2024-08-14 Société des Produits Nestlé S.A. Prebiotics for reducing the risk of obesity later in life
PL3212208T3 (pl) * 2014-10-29 2021-09-06 Biogaia Ab Zastosowanie bakterii l. reuteri do zapobiegania lub leczenia dysbiozy mikrobioty we wczesnych fazach życia
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
WO2017021479A1 (en) * 2015-08-04 2017-02-09 Nestec S.A. Nutritional compositions and infant formulas comprising bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
WO2017043963A1 (en) * 2015-09-11 2017-03-16 N.V. Nutricia Kit of parts for stimulating microbiota health after non-natural birth
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
EP3407741A1 (en) 2016-01-26 2018-12-05 Nestec S.A. Compositions with specific oligosaccharides to prevent or treat allergies
KR102692748B1 (ko) * 2016-05-31 2024-08-06 모리나가 뉴교 가부시키가이샤 뇌기능 개선제
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
CN109561723A (zh) * 2016-08-04 2019-04-02 雀巢产品技术援助有限公司 用于预防、治疗非轮状病毒相关性腹泻或降低其严重程度的包含低聚糖和任选地乳双歧杆菌的混合物的营养组合物和婴儿配方食品
BR112019020443A2 (pt) * 2017-05-05 2020-04-28 Nestle Sa tratamento de cólica em bebês
AU2018310705B2 (en) * 2017-08-04 2024-01-18 Societe Des Produits Nestle S.A. Probiotic bacteria preconditioned in a GOS-containing medium and use thereof
SG11202011820VA (en) * 2018-05-30 2020-12-30 Evolve Biosystems Inc Compostions and method of use for h5 competent bifidobacterium longum subsp. infantis
CN108935698A (zh) * 2018-09-11 2018-12-07 内蒙古伊利实业集团股份有限公司 一种预防小儿腹泻疾病的营养组合物及应用
CN109497271A (zh) * 2018-12-06 2019-03-22 江苏奥迈生物科技有限公司 一种提高断奶仔猪免疫力的复合饲料添加剂及其制备方法
KR102621775B1 (ko) * 2019-06-11 2024-01-08 씨제이바이오사이언스 주식회사 영유아의 장내 미생물 불균형도를 탐지하는 방법
TWI754302B (zh) * 2019-06-21 2022-02-01 大江生醫股份有限公司 乳雙歧桿菌tci604及其代謝產物的應用
CN111053244A (zh) * 2019-12-06 2020-04-24 山东体育学院 一种基于肠道微生物的营养调节方法及系统
CN111296711A (zh) * 2020-03-31 2020-06-19 广州纽缤乐营养科技股份有限公司 一种益生菌固体饮料及其制备方法
EP4180880A1 (fr) * 2021-11-10 2023-05-17 Montres Breguet S.A. Dispositif d'affichage d'une succession d'indications d'une grandeur temporelle pour une pièce d'horlogerie
KR20250022798A (ko) * 2022-06-10 2025-02-17 디에스엠 아이피 어셋츠 비.브이. 비타민 b2와 락토바실러스 람노서스를 포함하는 조합물
WO2023237687A1 (en) * 2022-06-10 2023-12-14 Dsm Ip Assets B.V. Combinations comprising vitamin b2 and lactobacillus rhamnosus
WO2024105265A1 (fr) 2022-11-17 2024-05-23 Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement Limosilactobacillus mucosae et désordres nécessitant un accroissement du niveau de glp-1
WO2024160209A1 (zh) * 2023-02-01 2024-08-08 北京三元食品股份有限公司 一株母乳来源的鼠李糖乳酪杆菌及应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
SU1743607A1 (ru) * 1990-02-05 1992-06-30 2-й Московский государственный медицинский институт им.Н.И.Пирогова Способ профилактики дисбактериоза кишечника у новорожденных детей
ATE161181T1 (de) 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
ATE172245T1 (de) * 1992-07-06 1998-10-15 Nestle Sa Milchbakterien
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
DE19958985A1 (de) * 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
WO2005000748A1 (en) 2003-06-27 2005-01-06 Bio-Circuit Aps A biogas producing facility with anaerobic hydrolysis
RU2428886C2 (ru) * 2005-04-13 2011-09-20 Нестек С.А. Смесь для грудных детей, содержащая пробиотики
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
MY146109A (en) 2006-02-10 2012-06-29 Nestec Sa Oligosaccharide mixture
EP1993576B1 (en) * 2006-03-07 2015-10-21 Nestec S.A. Synbiotic mixture
EP2035023A1 (en) * 2006-06-13 2009-03-18 Nestec S.A. Prevention and treatment of otitis media with non-pathogenic bacterial strains

Also Published As

Publication number Publication date
RU2521500C2 (ru) 2014-06-27
RU2009139658A (ru) 2011-05-10
UA97662C2 (ru) 2012-03-12
MX2009009442A (es) 2009-09-14
EP2131859A1 (en) 2009-12-16
WO2008116904A1 (en) 2008-10-02
EP2489280A2 (en) 2012-08-22
ES2577434T3 (es) 2016-07-14
BRPI0809626A2 (pt) 2014-09-23
CN101646452A (zh) 2010-02-10
ES2434566T3 (es) 2013-12-16
MX2009009931A (es) 2009-09-24
AU2008231775A1 (en) 2008-10-02
BRPI0809622A2 (pt) 2014-09-16
EP1974743A1 (en) 2008-10-01
CN101646453A (zh) 2010-02-10
RU2009139660A (ru) 2011-05-10
EP2489280A3 (en) 2013-06-26
PT2131680E (pt) 2013-10-28
EP2129242A1 (en) 2009-12-09
CA2678994A1 (en) 2008-03-27
BRPI0809356A2 (pt) 2014-09-02
CA2682654A1 (en) 2008-10-02
RU2009139667A (ru) 2011-05-10
US20100086527A1 (en) 2010-04-08
MX2009010252A (es) 2009-10-13
BRPI0809355A2 (pt) 2014-09-02
CN101652080A (zh) 2010-02-17
ZA200907731B (en) 2011-04-28
EP2129393A1 (en) 2009-12-09
US20100119488A1 (en) 2010-05-13
PL2131859T3 (pl) 2016-12-30
US20100119497A1 (en) 2010-05-13
MY151137A (en) 2014-04-30
AU2008231763B2 (en) 2013-10-31
EP2131680A1 (en) 2009-12-16
WO2008116907A1 (en) 2008-10-02
CN101652079A (zh) 2010-02-17
EP2131859B1 (en) 2016-04-27
EP2131680B1 (en) 2013-08-14
RU2009139669A (ru) 2011-05-10
RU2456008C2 (ru) 2012-07-20
AU2008231702A1 (en) 2008-10-02
PL2131680T3 (pl) 2014-01-31
US20100150874A1 (en) 2010-06-17
AU2008231763A1 (en) 2008-10-02
AU2008231702B2 (en) 2014-01-16
WO2008116892A1 (en) 2008-10-02
ZA200907538B (en) 2011-04-28
MX337667B (es) 2016-03-14
CA2680093A1 (en) 2008-10-02
ZA200907541B (en) 2011-04-28
UA97663C2 (ru) 2012-03-12
WO2008116916A1 (en) 2008-10-02
AU2008231778A1 (en) 2008-10-02
PT2131859T (pt) 2016-07-13
CA2679081A1 (en) 2008-10-02

Similar Documents

Publication Publication Date Title
MX2009009318A (es) Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea.
MY159072A (en) Probiotics to increase iga secretion in infants born by caesarean section
PH12014501749A1 (en) A nutritional composition comprising probiotics and improving sleep patterns
ZA200807879B (en) Use of bifidobacterium longum for the prevention and treatment of inflammation
MY158816A (en) Probiotics for reduction of risk of obesity
MX2009009670A (es) Reduccion de riesgo de diarrea.
ZA201207377B (en) Composition comprising probiotic bacteria for use in the treatment of immune disorders
MX2011009539A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso.
MY189329A (en) Mixture of non-digestible oligosaccharides for stimulating the immune system
MX2011007930A (es) Conjugados de insulina cristalina.
TW201711676A (en) Ferric citrate dosage forms
PH12014500558A1 (en) Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease
WO2009080800A3 (en) Method for decreasing abdominal girth by administering a bifidobacterium bacteria
ZA201109086B (en) Prevention and treatment of allergic diarrhoea
MY150931A (en) Substituted oxazolidinones and their use
MX2010002978A (es) Formulacion nutritiva con alto contenido energetico.
WO2014033574A3 (en) Protein stabilized probiotics and personal care products
GB2476418A (en) A medicinal product and treatment
MY146657A (en) Use of 4-cyclopropylmethoxy-n- (3,5-dichloro-1-oxido-pyridin-4-yl)-5-(methoxy) pyridine-2-carboxamide for the treatment of spinal cord traumas
MX2009011214A (es) Uso de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-4-piridin-4-il)- 5-(metoxi)piridin-2-carboxamida para el tratamiento de los traumatismos craneales.
RU2009125646A (ru) Способ коррекции микрофлоры кишечника
MY134740A (en) Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter
UA106224C2 (en) Crystalline insulin-conjugates
TH132246A (th) การใช้สิ่งสกัดถั่วเหลืองหมักในฐานะองค์ประกอบพรีไบโอติค
UA60203U (ru) Способ профилактики заболеваний желудочно-кишечного тракта у новорожденных телят

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal